•
Mar 31, 2020

Stryker Q1 2020 Earnings Report

Stryker's Q1 2020 results were affected by the COVID-19 pandemic, but the company reported a net sales increase and earnings growth.

Key Takeaways

Stryker reported a 2.0% increase in net sales, reaching $3.6 billion. Despite the negative impact of the COVID-19 pandemic, the company's reported EPS increased by 19.3% to $1.30, and net earnings increased by 19.7% to $493 million.

Net sales increased by 2.0% to $3.6 billion.

Organic net sales increased by 2.4%.

Reported EPS increased by 19.3% to $1.30.

Net earnings of $493 million, an increase of 19.7%.

Total Revenue
$3.59B
Previous year: $3.52B
+2.0%
EPS
$1.84
Previous year: $1.88
-2.1%
Organic Net Sales Growth
2.4%
Gross Profit
$2.33B
Previous year: $2.28B
+2.1%
Cash and Equivalents
$3.96B
Previous year: $1.67B
+136.8%
Free Cash Flow
$447M
Previous year: $191M
+134.0%
Total Assets
$29.4B
Previous year: $25.9B
+13.5%

Stryker

Stryker

Stryker Revenue by Segment

Stryker Revenue by Geographic Location

Forward Guidance

Due to the uncertain scope and duration of the pandemic, and uncertain timing of global recovery and economic normalization, Stryker will not be providing second quarter or full-year organic sales growth or earnings guidance for 2020.

Revenue & Expenses

Visualization of income flow from segment revenue to net income